YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21Waf1/Cip1
暂无分享,去创建一个
Fuqiang Li | Yong Cai | Jingji Jin | Tingting Wu | Fei Wang | Yi Sui
[1] N. Cruickshanks,et al. The p53 Pathway in Glioblastoma , 2018, Cancers.
[2] Hongjie Yao,et al. The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53‐binding site of the p21 gene in response to doxorubicin , 2018, The FEBS journal.
[3] Fuqiang Li,et al. BCCIP binds to and activates its promoter in a YY1‐dependent fashion in HCT116 cells , 2018, The FEBS journal.
[4] A. Strasser,et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? , 2018 .
[5] Doo Sin Jo,et al. Up-regulation of UVRAG by HDAC1 Inhibition Attenuates 5FU-induced Cell Death in HCT116 Colorectal Cancer Cells. , 2018, Anticancer research.
[6] A. Strasser,et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? , 2017, Cell Death and Differentiation.
[7] Fuqiang Li,et al. Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells , 2016, Protein & Cell.
[8] Fei Wang,et al. Negative Regulation of p21Waf1/Cip1 by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability , 2015, PloS one.
[9] L. Attardi,et al. Unravelling mechanisms of p53-mediated tumour suppression , 2014, Nature Reviews Cancer.
[10] Wei Gu,et al. Understanding the non-canonical pathways involved in p53-mediated tumor suppression. , 2014, Carcinogenesis.
[11] G. Del Sal,et al. Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death , 2013, Proceedings of the National Academy of Sciences.
[12] L. Attardi,et al. p53 at a glance , 2010, Journal of Cell Science.
[13] M. Washburn,et al. YY1 functions with INO80 to activate transcription , 2007, Nature Structural &Molecular Biology.
[14] Zhiyuan Shen,et al. Abrogation of the Transactivation Activity of p53 by BCCIP Down-regulation* , 2007, Journal of Biological Chemistry.
[15] A. Efeyan,et al. Tumour biology: Policing of oncogene activity by p53 , 2006, Nature.
[16] M. Bucan,et al. Promoter features related to tissue specificity as measured by Shannon entropy , 2005, Genome Biology.
[17] Zhiyuan Shen,et al. BCCIP Functions through p53 to Regulate the Expression of p21Waf1/Cip1 , 2004, Cell cycle.
[18] S. Grossman,et al. Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.
[19] T. Ekström,et al. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. , 2004, Biochemical and biophysical research communications.
[20] Yoshiharu Kawaguchi,et al. MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation , 2002, The EMBO journal.
[21] Ya-Li Yao,et al. Regulation of Transcription Factor YY1 by Acetylation and Deacetylation , 2001, Molecular and Cellular Biology.
[22] Yuan Yuan,et al. Inhibition of breast and brain cancer cell growth by BCCIPα, an evolutionarily conserved nuclear protein that interacts with BRCA2 , 2001, Oncogene.
[23] G. Pasz-Walczak,et al. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis. , 2001, Pathology, research and practice.
[24] K. Vousden,et al. Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .
[25] S. Iguchi-Ariga,et al. TOK-1, a Novel p21Cip1-binding Protein That Cooperatively Enhances p21-dependent Inhibitory Activity toward CDK2 Kinase* , 2000, The Journal of Biological Chemistry.
[26] E. Seto,et al. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.
[27] Jeng-Shin Lee,et al. Everything you have ever wanted to know about Yin Yang 1...... , 1997, Biochimica et biophysica acta.
[28] J. Chuang,et al. Transcriptional Regulation by p53 , 1995, The Journal of Biological Chemistry.
[29] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[30] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.